 Home > Medical News > Medical World News > Health Commission: Management indicators for the reasonable clinical application of anti-tumor drugs

Health Commission: Management indicators for the reasonable clinical application of anti-tumor drugs

 Last Update: 2021-08-09
 Source: Internet
 Author: User

Tags

waste management spokane

anti tnf

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Medical Network, June 29 News On June 28, the National Health Commission issued a message to guide medical institutions to scientifically set management indicators for the clinical application of anti-tumor drugs and improve the level of reasonable clinical application of anti-tumor drugs.
The National Health and Health Commission organized the formulation and Released the "Management Indicators for the Rational Application of Anti-tumor Drugs (2021 Edition)"
.
Reads as follows:
National Health Health Committee General Office on the issuance of anti -tumor clinical drug rational use of management indicators (2021 edition) notice
AXA organized medicine Han [2021] 336
provinces, autonomous regions and municipalities and Xinjiang Production and Construction Corps health committee: for the Implement the "Administrative Measures for the Clinical Application of Anti-tumor Drugs (Trial)" (Guowei Medical Letter [2020] No.
487), guide medical institutions to scientifically set management indicators for the clinical application of anti-tumor drugs, and improve the level of reasonable clinical application of anti-tumor drugs.
The Commission organized the formulation of the "Management Indicators for the Rational Application of Anti-tumor Drugs (2021 Edition)"
.
Now it is issued to you, please refer to the implementation
.
Attachment: Management Indicators for the Rational Application of Anti-tumor Drugs (2021 Edition)
General Office of the National Health Commission June 17, 2021

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

4-ISOPROPYL-4'-METHYLDIPHENYLIODONIUM TETRAKIS(PENTAFLUOROPHENYL)BORATE

CAS No.: 178233-72-2

$1/KG EXW

4-hydroxy-N'-(2-naphthylmethylene)benzohydrazide HL

CAS No.: 303760-60-3

$9.9/G FOB

Dydrogesterone, CAS:152-62-5

CAS No.: 152-62-5

Pharmacy Grade

$300-350/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.